Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: June 25, 2024
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
Journal: The New England journal of medicine
Published: May 24, 2023
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: August 13, 2021
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression.
Journal: Contemporary clinical trials communications
Published: April 24, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Journal: Molecular psychiatry
Published: January 09, 2019
ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
Journal: Contemporary clinical trials
Published: August 10, 2018
Fibreoptic Orotracheal Intubation of Obese Patients Using Parker Flex-Tip vs. Standard Endotracheal Tube.
Journal: Turkish journal of anaesthesiology and reanimation
Published: July 17, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Journal: Molecular psychiatry
Published: December 04, 2017
Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 27, 2014
Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
Journal: Depression and anxiety
Published: December 16, 2013
Ketamine safety and tolerability in clinical trials for treatment-resistant depression.
Journal: The Journal of clinical psychiatry
Published: October 22, 2013
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.
Journal: The international journal of neuropsychopharmacology
Published: October 10, 2013
Last Updated: 09/26/2026